Sfoglia per AUTORE
BALMA M
Collezione AO Cuneo

  

Items : 8

Can Baseline [(18)F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study. in Cancer biotherapy & radiopharmaceuticals / Cancer Biother Radiopharm. 2023 May;38(4):256-267. doi: 10.1089/cbr.2022.0092. Epub 2023 Apr 25.

2023
AO Cuneo

Bianchi A; De Rimini ML; Sciuto R; Annovazzi A; Di Traglia S; Bauckneht M; Lanfranchi F; Morbelli S; Nappi AG; Ferrari C; Rubini G; Panareo S; Urso L; Bartolomei M; D'Arienzo D; Valente T; Rossetti V; Caroli P; Matteucci F; Aricò D; Bombaci M; Caponnetto D; Bertagna F; Albano D; Dondi F; Gusella S; Spimpolo A; Carriere C; Balma M; et alii...

(18)F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data. in Endocrine / Endocrine. 2023 May;80(2):433-440. doi: 10.1007/s12020-022-03280-9. Epub 2022 Dec 10.

2023
AO Cuneo
AOU Città della Salute di Torino

Palestini N; Freddi M; Bruna MC; Dionisi B; Mossetti C; Balma M; Dall'Armellina S; Cauda S; Rizzo A; Racca M;

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs). in Life (Basel, Switzerland) / Life (Basel). 2023 Jul 28;13(8):1647. doi: 10.3390/life13081647.

2023
AO Cuneo
AOU Città della Salute di Torino

Evangelista L; Deandreis D; Farsad M; Rampado O; Peano S; Costa RP; Lorenzon L; Gusella S; Gallio E; Laudicella R; Balma M; Papaleo A; Liberini V;

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. in Cancers / Cancers (Basel). 2023 Jan 31;15(3):878. doi: 10.3390/cancers15030878.

2023
AO Cuneo

Evangelista L; Bianchi A; Annovazzi A; Sciuto R; Di Traglia S; Bauckneht M; Lanfranchi F; Morbelli S; Nappi AG; Ferrari C; Rubini G; Panareo S; Urso L; Bartolomei M; D'Arienzo D; Valente T; Rossetti V; Caroli P; Matteucci F; Aricò D; Bombaci M; Caponnetto D; Bertagna F; Albano D; Dondi F; Gusella S; Spimpolo A; Carriere C; Balma M; et alii...

The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years. in Current medical imaging / Curr Med Imaging. 2023;19(8):817-831. doi: 10.2174/1573405619666230216114748.

2023
AO Cuneo

Balma M; Liberini V; Buschiazzo A; Racca M; Rizzo A; Nicolotti DG; Laudicella R; Quartuccio N; Longo M; Perlo G; Terreno E; Abgral R; William Huellner M; Papaleo A; Deandreis D;

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics. in European radiology experimental / Eur Radiol Exp. 2022 Jun 15;6(1):27. doi: 10.1186/s41747-022-00282-0.

2022
AO Cuneo
AOU Città della Salute di Torino

Huellner MW; Papaleo A; Farsad M; Baldari S; Burger IA; Lorenzon L; Bianchi A; Peano S; Bartolotta TV; Grimaldi S; Buschiazzo A; Balma M; Nicolotti DG; Laudicella R; Liberini V; Deandreis D;

Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review. in Frontiers in medicine / Front Med (Lausanne). 2022 Apr 12;9:881551. doi: 10.3389/fmed.2022.881551. eCollection 2022.

2022
AO Cuneo

Balma M; Liberini V; Racca M; Laudicella R; Bauckneht M; Buschiazzo A; Nicolotti DG; Peano S; Bianchi A; Albano G; Quartuccio N; Abgral R; Morbelli SD; D'Alessandria C; Terreno E; Huellner MW; Papaleo A; Deandreis D;

18F-FDG PET/CT SUVmax correlates with histological subtype and Sica-travis score? in pathological stage I adenocarcinoma of the lung in European Journal of Nuclear Medicine and Molecular Imaging

2014
AO Cuneo
ASL Città di Torino

Orsini F; Puta E; Leva L; Boldorini R; Santos Pereira P; Casadio C; Rena O; Sacchetti GM; Terulla A; Bergesio F; Roberto E; Sortino D; Biggi A; Grosso M; Chauvie S; Skanjeti A; Castellano G; Elia BO; Zotta M; Grimaldi S; Balma M; Iudicello M; Zibetti M; Ferrero P; Filippi P; Pellerito RE; Podio V;